Industry: Service & Software
Published Date: 2024-11-12
Pages: 93 Pages
Report ld: 3372766
Request Sample
Customized Report
The global Virus-like Particles (VLPs) Delivery System revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
In United States the Virus-like Particles (VLPs) Delivery System revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Virus-like Particles (VLPs) Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose their original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.
The global key players of Virus-like Particles (VLPs) Delivery System include WuXi Biologics, Creative Biolabs, Creative Biogene, Creative Biostructure, Cusabio Technology LLC, Creative Diagnostics, ARTES Biotechnology GmbH, etc. The global five biggest players hold a share of % in 2023.
Global Virus-like Particles (VLPs) Delivery System Scope and Market Size
Virus-like Particles (VLPs) Delivery System market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Virus-like Particles (VLPs) Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Virus-like Particles (VLPs) Delivery System market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Virus-like Particles (VLPs) Delivery System definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Virus-like Particles (VLPs) Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Virus-like Particles (VLPs) Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Virus-like Particles (VLPs) Delivery System revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Virus-like Particles (VLPs) Delivery System Product Introduction
1.2 Global Virus-like Particles (VLPs) Delivery System Outlook, 2019 VS 2023 VS 2030
1.2.1 Global Virus-like Particles (VLPs) Delivery System Market Size for the Year 2019-2030
1.2.2 United States Virus-like Particles (VLPs) Delivery System Market Size for the Year 2019-2030
1.3 Virus-like Particles (VLPs) Delivery System Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.3.1 The Market Share of United States Virus-like Particles (VLPs) Delivery System in Global, 2019 VS 2023 VS 2030
1.3.2 The Growth Rate of Virus-like Particles (VLPs) Delivery System Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4 Virus-like Particles (VLPs) Delivery System Market Dynamics
1.4.1 Virus-like Particles (VLPs) Delivery System Industry Trends
1.4.2 Virus-like Particles (VLPs) Delivery System Market Drivers
1.4.3 Virus-like Particles (VLPs) Delivery System Market Challenges
1.4.4 Virus-like Particles (VLPs) Delivery System Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Virus-like Particles (VLPs) Delivery System by Type
2.1 Virus-like Particles (VLPs) Delivery System Market by Type
2.1.1 Insect Cell System
2.1.2 Mammalian Cell System
2.1.3 Plant System
2.1.4 Yeast System
2.1.5 E. coli System
2.2 Global Virus-like Particles (VLPs) Delivery System Market Size by Type (2019, 2023 & 2030)
2.3 Global Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2030)
2.4 United States Virus-like Particles (VLPs) Delivery System Market Size by Type (2019, 2023 & 2030)
2.5 United States Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2030)
3 Virus-like Particles (VLPs) Delivery System by Application
3.1 Virus-like Particles (VLPs) Delivery System Market by Application
3.1.1 DNA
3.1.2 RNA
3.1.3 Peptide
3.1.4 Protein
3.1.5 Other
3.2 Global Virus-like Particles (VLPs) Delivery System Market Size, by Application (2019, 2023 & 2030)
3.3 Global Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2030)
3.4 United States Virus-like Particles (VLPs) Delivery System Market Size by Application (2019, 2023 & 2030)
3.5 United States Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2030)
4 Global Virus-like Particles (VLPs) Delivery System Competitor Landscape by Company
4.1 Global Virus-like Particles (VLPs) Delivery System Market Size by Company
4.1.1 Global Key Companies of Virus-like Particles (VLPs) Delivery System, Ranked by Revenue (2023)
4.1.2 Global Virus-like Particles (VLPs) Delivery System Revenue by Player (2019-2024)
4.2 Global Virus-like Particles (VLPs) Delivery System Concentration Ratio (CR)
4.2.1 Virus-like Particles (VLPs) Delivery System Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Companies of Virus-like Particles (VLPs) Delivery System in 2023
4.2.3 Global Virus-like Particles (VLPs) Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Virus-like Particles (VLPs) Delivery System Head office and Area Served
4.4 Global Key Players of Virus-like Particles (VLPs) Delivery System, Product and Application
4.5 Global Key Players of Virus-like Particles (VLPs) Delivery System, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Virus-like Particles (VLPs) Delivery System Market Size by Company
4.7.1 Key Players of Virus-like Particles (VLPs) Delivery System in United States, Ranked by Revenue (2023)
4.7.2 United States Virus-like Particles (VLPs) Delivery System Revenue by Players (2022, 2023 & 2024)
5 Global Virus-like Particles (VLPs) Delivery System Market Size by Region
5.1 Global Virus-like Particles (VLPs) Delivery System Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Virus-like Particles (VLPs) Delivery System Market Size by Region (2019-2030)
5.2.1 Global Virus-like Particles (VLPs) Delivery System Market Size by Region: 2019-2024
5.2.2 Global Virus-like Particles (VLPs) Delivery System Market Size by Region: 2025-2030
6 Americas
6.1 Americas Virus-like Particles (VLPs) Delivery System Market Size YoY Growth 2019-2030
6.2 Americas Virus-like Particles (VLPs) Delivery System Market Size by Type
6.2.1 Americas Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)
6.2.2 Americas Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)
6.2.3 Americas Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
6.3 Americas Virus-like Particles (VLPs) Delivery System Market Size by Application
6.3.1 Americas Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)
6.3.2 Americas Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)
6.3.3 Americas Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
6.4 Americas Virus-like Particles (VLPs) Delivery System Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Virus-like Particles (VLPs) Delivery System Market Size YoY Growth 2019-2030
7.2 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Type
7.2.1 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)
7.2.2 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)
7.2.3 EMEA Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
7.3 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Application
7.3.1 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)
7.3.2 EMEA Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)
7.3.3 EMEA Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
7.4 EMEA Virus-like Particles (VLPs) Delivery System Market Facts & Figures by Region (2019, 2023 & 2030)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Virus-like Particles (VLPs) Delivery System Market Size by Type
8.1.1 China Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)
8.1.2 China Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)
8.1.3 China Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
8.2 China Virus-like Particles (VLPs) Delivery System Market Size by Application
8.2.1 China Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)
8.2.2 China Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)
8.2.3 China Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Virus-like Particles (VLPs) Delivery System Market Size YoY Growth 2019-2030
9.2 APAC Virus-like Particles (VLPs) Delivery System Market Size by Type
9.2.1 APAC Virus-like Particles (VLPs) Delivery System Market Size by Type (2019-2024)
9.2.2 APAC Virus-like Particles (VLPs) Delivery System Market Size by Type (2025-2030)
9.2.3 APAC Virus-like Particles (VLPs) Delivery System Market Share by Type (2019-2030)
9.3 APAC Virus-like Particles (VLPs) Delivery System Market Size by Application
9.3.1 APAC Virus-like Particles (VLPs) Delivery System Market Size by Application (2019-2024)
9.3.2 APAC Virus-like Particles (VLPs) Delivery System Market Size by Application (2025-2030)
9.3.3 APAC Virus-like Particles (VLPs) Delivery System Market Share by Application (2019-2030)
9.4 APAC Virus-like Particles (VLPs) Delivery System Market Facts & Figures by Region (2019, 2023 & 2030)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 ASEAN
9.4.5 India
10 Key Players Profiles
10.1 WuXi Biologics
10.1.1 WuXi Biologics Company Details
10.1.2 WuXi Biologics Business Overview
10.1.3 WuXi Biologics Virus-like Particles (VLPs) Delivery System Introduction
10.1.4 WuXi Biologics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.1.5 WuXi Biologics Recent Development
10.2 Creative Biolabs
10.2.1 Creative Biolabs Company Details
10.2.2 Creative Biolabs Business Overview
10.2.3 Creative Biolabs Virus-like Particles (VLPs) Delivery System Introduction
10.2.4 Creative Biolabs Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.2.5 Creative Biolabs Recent Development
10.3 Creative Biogene
10.3.1 Creative Biogene Company Details
10.3.2 Creative Biogene Business Overview
10.3.3 Creative Biogene Virus-like Particles (VLPs) Delivery System Introduction
10.3.4 Creative Biogene Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.3.5 Creative Biogene Recent Development
10.4 Creative Biostructure
10.4.1 Creative Biostructure Company Details
10.4.2 Creative Biostructure Business Overview
10.4.3 Creative Biostructure Virus-like Particles (VLPs) Delivery System Introduction
10.4.4 Creative Biostructure Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.4.5 Creative Biostructure Recent Development
10.5 Cusabio Technology LLC
10.5.1 Cusabio Technology LLC Company Details
10.5.2 Cusabio Technology LLC Business Overview
10.5.3 Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Introduction
10.5.4 Cusabio Technology LLC Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.5.5 Cusabio Technology LLC Recent Development
10.6 Creative Diagnostics
10.6.1 Creative Diagnostics Company Details
10.6.2 Creative Diagnostics Business Overview
10.6.3 Creative Diagnostics Virus-like Particles (VLPs) Delivery System Introduction
10.6.4 Creative Diagnostics Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.6.5 Creative Diagnostics Recent Development
10.7 ARTES Biotechnology GmbH
10.7.1 ARTES Biotechnology GmbH Company Details
10.7.2 ARTES Biotechnology GmbH Business Overview
10.7.3 ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Introduction
10.7.4 ARTES Biotechnology GmbH Revenue in Virus-like Particles (VLPs) Delivery System Business (2019-2024)
10.7.5 ARTES Biotechnology GmbH Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-25
Pages: 120
USD 4900.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 107
USD 2900.00
(Single User License)
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 94
USD 3950.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-01
Pages: 121
USD 4900.00
(Single User License)
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 99
USD 3950.00
(Single User License)
The global market for Virus-like Particles (VLPs) Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 71
USD 2900.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 129
USD 4900.00
(Single User License)
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-11-12
Pages: 91
USD 3950.00
(Single User License)
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-25
Pages: 120
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
The global Virus-like Particles (VLPs) Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 107
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 94
The global Virus-like Particles (VLPs) Delivery System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-01
Pages: 121
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 99
The global market for Virus-like Particles (VLPs) Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 71
The global Virus-like Particles (VLPs) Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 129
The global market for Virus-like Particles (VLPs) Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-11-12
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now